Global Drugs Based on Gene Therapy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Drugs Based on Gene Therapy Market Insights, Forecast to 2034

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery
Market Analysis and InsightsGlobal Drugs Based on Gene Therapy Market
Global Drugs Based on Gene Therapy market is expected to reach to US$ 11590 million in 2024, with a positive growth of %, compared with US$ 9063 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Drugs Based on Gene Therapy industry is evaluated to reach US$ 34850 million in 2029. The CAGR will be 20.2% during 2024 to 2029.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
Report Covers
This report presents an overview of global Drugs Based on Gene Therapy market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Drugs Based on Gene Therapy market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report

By Company

Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type
Based on Viral
Based on Non-viral

Segment by Application

Neurological Diseases
Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline

Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Drugs Based on Gene Therapy introduction, etc. Drugs Based on Gene Therapy Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Drugs Based on Gene Therapy
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs Based on Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Based on Viral
1.2.3 Based on Non-viral
1.3 Market by Application
1.3.1 Global Drugs Based on Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs Based on Gene Therapy Market Perspective (2018-2029)
2.2 Global Drugs Based on Gene Therapy Growth Trends by Region
2.2.1 Drugs Based on Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drugs Based on Gene Therapy Historic Market Size by Region (2018-2024)
2.2.3 Drugs Based on Gene Therapy Forecasted Market Size by Region (2024-2029)
2.3 Drugs Based on Gene Therapy Market Dynamics
2.3.1 Drugs Based on Gene Therapy Industry Trends
2.3.2 Drugs Based on Gene Therapy Market Drivers
2.3.3 Drugs Based on Gene Therapy Market Challenges
2.3.4 Drugs Based on Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drugs Based on Gene Therapy by Players
3.1.1 Global Drugs Based on Gene Therapy Revenue by Players (2018-2024)
3.1.2 Global Drugs Based on Gene Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Drugs Based on Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drugs Based on Gene Therapy, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Drugs Based on Gene Therapy Market Concentration Ratio
3.4.1 Global Drugs Based on Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs Based on Gene Therapy Revenue in 2022
3.5 Global Key Players of Drugs Based on Gene Therapy Head office and Area Served
3.6 Global Key Players of Drugs Based on Gene Therapy, Product and Application
3.7 Global Key Players of Drugs Based on Gene Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs Based on Gene Therapy Breakdown Data by Type
4.1 Global Drugs Based on Gene Therapy Historic Market Size by Type (2018-2024)
4.2 Global Drugs Based on Gene Therapy Forecasted Market Size by Type (2024-2029)
5 Drugs Based on Gene Therapy Breakdown Data by Application
5.1 Global Drugs Based on Gene Therapy Historic Market Size by Application (2018-2024)
5.2 Global Drugs Based on Gene Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drugs Based on Gene Therapy Market Size (2018-2029)
6.2 North America Drugs Based on Gene Therapy Market Size by Type
6.2.1 North America Drugs Based on Gene Therapy Market Size by Type (2018-2024)
6.2.2 North America Drugs Based on Gene Therapy Market Size by Type (2024-2029)
6.2.3 North America Drugs Based on Gene Therapy Market Share by Type (2018-2029)
6.3 North America Drugs Based on Gene Therapy Market Size by Application
6.3.1 North America Drugs Based on Gene Therapy Market Size by Application (2018-2024)
6.3.2 North America Drugs Based on Gene Therapy Market Size by Application (2024-2029)
6.3.3 North America Drugs Based on Gene Therapy Market Share by Application (2018-2029)
6.4 North America Drugs Based on Gene Therapy Market Size by Country
6.4.1 North America Drugs Based on Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Drugs Based on Gene Therapy Market Size by Country (2018-2024)
6.4.3 North America Drugs Based on Gene Therapy Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Drugs Based on Gene Therapy Market Size (2018-2029)
7.2 Europe Drugs Based on Gene Therapy Market Size by Type
7.2.1 Europe Drugs Based on Gene Therapy Market Size by Type (2018-2024)
7.2.2 Europe Drugs Based on Gene Therapy Market Size by Type (2024-2029)
7.2.3 Europe Drugs Based on Gene Therapy Market Share by Type (2018-2029)
7.3 Europe Drugs Based on Gene Therapy Market Size by Application
7.3.1 Europe Drugs Based on Gene Therapy Market Size by Application (2018-2024)
7.3.2 Europe Drugs Based on Gene Therapy Market Size by Application (2024-2029)
7.3.3 Europe Drugs Based on Gene Therapy Market Share by Application (2018-2029)
7.4 Europe Drugs Based on Gene Therapy Market Size by Country
7.4.1 Europe Drugs Based on Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Drugs Based on Gene Therapy Market Size by Country (2018-2024)
7.4.3 Europe Drugs Based on Gene Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drugs Based on Gene Therapy Market Size (2018-2029)
8.2 China Drugs Based on Gene Therapy Market Size by Type
8.2.1 China Drugs Based on Gene Therapy Market Size by Type (2018-2024)
8.2.2 China Drugs Based on Gene Therapy Market Size by Type (2024-2029)
8.2.3 China Drugs Based on Gene Therapy Market Share by Type (2018-2029)
8.3 China Drugs Based on Gene Therapy Market Size by Application
8.3.1 China Drugs Based on Gene Therapy Market Size by Application (2018-2024)
8.3.2 China Drugs Based on Gene Therapy Market Size by Application (2024-2029)
8.3.3 China Drugs Based on Gene Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Drugs Based on Gene Therapy Market Size (2018-2029)
9.2 Asia Drugs Based on Gene Therapy Market Size by Type
9.2.1 Asia Drugs Based on Gene Therapy Market Size by Type (2018-2024)
9.2.2 Asia Drugs Based on Gene Therapy Market Size by Type (2024-2029)
9.2.3 Asia Drugs Based on Gene Therapy Market Share by Type (2018-2029)
9.3 Asia Drugs Based on Gene Therapy Market Size by Application
9.3.1 Asia Drugs Based on Gene Therapy Market Size by Application (2018-2024)
9.3.2 Asia Drugs Based on Gene Therapy Market Size by Application (2024-2029)
9.3.3 Asia Drugs Based on Gene Therapy Market Share by Application (2018-2029)
9.4 Asia Drugs Based on Gene Therapy Market Size by Region
9.4.1 Asia Drugs Based on Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Drugs Based on Gene Therapy Market Size by Region (2018-2024)
9.4.3 Asia Drugs Based on Gene Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Drugs Based on Gene Therapy Introduction
11.1.4 Biogen Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.1.5 Biogen Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Drugs Based on Gene Therapy Introduction
11.2.4 Novartis Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.2.5 Novartis Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Drugs Based on Gene Therapy Introduction
11.3.4 Gilead Sciences Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.3.5 Gilead Sciences Recent Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Drugs Based on Gene Therapy Introduction
11.4.4 Sarepta Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.4.5 Sarepta Therapeutics Recent Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Drugs Based on Gene Therapy Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.5.5 Alnylam Pharmaceuticals Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Drugs Based on Gene Therapy Introduction
11.6.4 Amgen Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.6.5 Amgen Recent Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Drugs Based on Gene Therapy Introduction
11.7.4 Spark Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.7.5 Spark Therapeutics Recent Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Drugs Based on Gene Therapy Introduction
11.8.4 Akcea Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.8.5 Akcea Therapeutics Recent Developments
11.9 Bluebird bio
11.9.1 Bluebird bio Company Details
11.9.2 Bluebird bio Business Overview
11.9.3 Bluebird bio Drugs Based on Gene Therapy Introduction
11.9.4 Bluebird bio Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.9.5 Bluebird bio Recent Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Details
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Drugs Based on Gene Therapy Introduction
11.10.4 Sunway Biotech Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.10.5 Sunway Biotech Recent Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Details
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Drugs Based on Gene Therapy Introduction
11.11.4 SIBIONO Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.11.5 SIBIONO Recent Developments
11.12 AnGes
11.12.1 AnGes Company Details
11.12.2 AnGes Business Overview
11.12.3 AnGes Drugs Based on Gene Therapy Introduction
11.12.4 AnGes Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.12.5 AnGes Recent Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Details
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Drugs Based on Gene Therapy Introduction
11.13.4 Orchard Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.13.5 Orchard Therapeutics Recent Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Details
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Drugs Based on Gene Therapy Introduction
11.14.4 Human Stem Cells Institute Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.14.5 Human Stem Cells Institute Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drugs Based on Gene Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Based on Viral
Table 3. Key Players of Based on Non-viral
Table 4. Global Drugs Based on Gene Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Drugs Based on Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Drugs Based on Gene Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Drugs Based on Gene Therapy Market Share by Region (2018-2024)
Table 8. Global Drugs Based on Gene Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Drugs Based on Gene Therapy Market Share by Region (2024-2029)
Table 10. Drugs Based on Gene Therapy Market Trends
Table 11. Drugs Based on Gene Therapy Market Drivers
Table 12. Drugs Based on Gene Therapy Market Challenges
Table 13. Drugs Based on Gene Therapy Market Restraints
Table 14. Global Drugs Based on Gene Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Drugs Based on Gene Therapy Revenue Share by Players (2018-2024)
Table 16. Global Top Drugs Based on Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs Based on Gene Therapy as of 2022)
Table 17. Global Drugs Based on Gene Therapy Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Drugs Based on Gene Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Drugs Based on Gene Therapy, Headquarters and Area Served
Table 20. Global Key Players of Drugs Based on Gene Therapy, Product and Application
Table 21. Global Key Players of Drugs Based on Gene Therapy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drugs Based on Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Drugs Based on Gene Therapy Revenue Market Share by Type (2018-2024)
Table 25. Global Drugs Based on Gene Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Drugs Based on Gene Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Drugs Based on Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Drugs Based on Gene Therapy Revenue Share by Application (2018-2024)
Table 29. Global Drugs Based on Gene Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Drugs Based on Gene Therapy Revenue Share by Application (2024-2029)
Table 31. North America Drugs Based on Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Drugs Based on Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Drugs Based on Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Drugs Based on Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Drugs Based on Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Drugs Based on Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Drugs Based on Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Drugs Based on Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Drugs Based on Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Drugs Based on Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Drugs Based on Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Drugs Based on Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Drugs Based on Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Drugs Based on Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Drugs Based on Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Drugs Based on Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Drugs Based on Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Drugs Based on Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Drugs Based on Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Drugs Based on Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Drugs Based on Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Drugs Based on Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Drugs Based on Gene Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Drugs Based on Gene Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Drugs Based on Gene Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drugs Based on Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 63. Biogen Company Details
Table 64. Biogen Business Overview
Table 65. Biogen Drugs Based on Gene Therapy Product
Table 66. Biogen Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 67. Biogen Recent Developments
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Drugs Based on Gene Therapy Product
Table 71. Novartis Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 72. Novartis Recent Developments
Table 73. Gilead Sciences Company Details
Table 74. Gilead Sciences Business Overview
Table 75. Gilead Sciences Drugs Based on Gene Therapy Product
Table 76. Gilead Sciences Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 77. Gilead Sciences Recent Developments
Table 78. Sarepta Therapeutics Company Details
Table 79. Sarepta Therapeutics Business Overview
Table 80. Sarepta Therapeutics Drugs Based on Gene Therapy Product
Table 81. Sarepta Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 82. Sarepta Therapeutics Recent Developments
Table 83. Alnylam Pharmaceuticals Company Details
Table 84. Alnylam Pharmaceuticals Business Overview
Table 85. Alnylam Pharmaceuticals Drugs Based on Gene Therapy Product
Table 86. Alnylam Pharmaceuticals Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 87. Alnylam Pharmaceuticals Recent Developments
Table 88. Amgen Company Details
Table 89. Amgen Business Overview
Table 90. Amgen Drugs Based on Gene Therapy Product
Table 91. Amgen Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 92. Amgen Recent Developments
Table 93. Spark Therapeutics Company Details
Table 94. Spark Therapeutics Business Overview
Table 95. Spark Therapeutics Drugs Based on Gene Therapy Product
Table 96. Spark Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 97. Spark Therapeutics Recent Developments
Table 98. Akcea Therapeutics Company Details
Table 99. Akcea Therapeutics Business Overview
Table 100. Akcea Therapeutics Drugs Based on Gene Therapy Product
Table 101. Akcea Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 102. Akcea Therapeutics Recent Developments
Table 103. Bluebird bio Company Details
Table 104. Bluebird bio Business Overview
Table 105. Bluebird bio Drugs Based on Gene Therapy Product
Table 106. Bluebird bio Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 107. Bluebird bio Recent Developments
Table 108. Sunway Biotech Company Details
Table 109. Sunway Biotech Business Overview
Table 110. Sunway Biotech Drugs Based on Gene Therapy Product
Table 111. Sunway Biotech Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 112. Sunway Biotech Recent Developments
Table 113. SIBIONO Company Details
Table 114. SIBIONO Business Overview
Table 115. SIBIONO Drugs Based on Gene Therapy Product
Table 116. SIBIONO Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 117. SIBIONO Recent Developments
Table 118. AnGes Company Details
Table 119. AnGes Business Overview
Table 120. AnGes Drugs Based on Gene Therapy Product
Table 121. AnGes Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 122. AnGes Recent Developments
Table 123. Orchard Therapeutics Company Details
Table 124. Orchard Therapeutics Business Overview
Table 125. Orchard Therapeutics Drugs Based on Gene Therapy Product
Table 126. Orchard Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 127. Orchard Therapeutics Recent Developments
Table 128. Human Stem Cells Institute Company Details
Table 129. Human Stem Cells Institute Business Overview
Table 130. Human Stem Cells Institute Drugs Based on Gene Therapy Product
Table 131. Human Stem Cells Institute Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 132. Human Stem Cells Institute Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs Based on Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Drugs Based on Gene Therapy Market Share by Type: 2022 VS 2029
Figure 3. Based on Viral Features
Figure 4. Based on Non-viral Features
Figure 5. Global Drugs Based on Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Drugs Based on Gene Therapy Market Share by Application: 2022 VS 2029
Figure 7. Neurological Diseases Case Studies
Figure 8. Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Drugs Based on Gene Therapy Report Years Considered
Figure 11. Global Drugs Based on Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Drugs Based on Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Drugs Based on Gene Therapy Market Share by Region: 2022 VS 2029
Figure 14. Global Drugs Based on Gene Therapy Market Share by Players in 2022
Figure 15. Global Top Drugs Based on Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs Based on Gene Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Drugs Based on Gene Therapy Revenue in 2022
Figure 17. North America Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Drugs Based on Gene Therapy Market Share by Type (2018-2029)
Figure 19. North America Drugs Based on Gene Therapy Market Share by Application (2018-2029)
Figure 20. North America Drugs Based on Gene Therapy Market Share by Country (2018-2029)
Figure 21. United States Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Drugs Based on Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Drugs Based on Gene Therapy Market Share by Type (2018-2029)
Figure 25. Europe Drugs Based on Gene Therapy Market Share by Application (2018-2029)
Figure 26. Europe Drugs Based on Gene Therapy Market Share by Country (2018-2029)
Figure 27. Germany Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Drugs Based on Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Drugs Based on Gene Therapy Market Share by Type (2018-2029)
Figure 35. China Drugs Based on Gene Therapy Market Share by Application (2018-2029)
Figure 36. Asia Drugs Based on Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Drugs Based on Gene Therapy Market Share by Type (2018-2029)
Figure 38. Asia Drugs Based on Gene Therapy Market Share by Application (2018-2029)
Figure 39. Asia Drugs Based on Gene Therapy Market Share by Region (2018-2029)
Figure 40. Japan Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Drugs Based on Gene Therapy Market Share by Country (2018-2029)
Figure 50. Brazil Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Biogen Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 57. Novartis Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 58. Gilead Sciences Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 59. Sarepta Therapeutics Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 60. Alnylam Pharmaceuticals Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 61. Amgen Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 62. Spark Therapeutics Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 63. Akcea Therapeutics Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 64. Bluebird bio Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 65. Sunway Biotech Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 66. SIBIONO Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 67. AnGes Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 68. Orchard Therapeutics Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 69. Human Stem Cells Institute Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Global Drugs Based on Gene Therapy Market Insights, Forecast to 2034

Global Drugs Based on Gene Therapy Market Insights, Forecast to 2034

By Company

Segment by Application

Chapter Outline

Table of Content

List of Figure

Select User License

$4200 Single Licence

$6000 Enterprise Licence

$9100 Corporate Licence

Note : All prices in USD

FAQ'S

User License?

Delivery Time?

How do I place an order?

What is the Payment Options?

Is there a discount for multiple purchases?

Mode of Report Delivery?

Top Industries